1Department of Surgery, Cornell University Medical College, New York, New York.
Cytoreduction, or tumor burden reduction, enhances cancer treatment sensitivity in laboratory studies by improving drug efficacy and reducing resistance. Clinical benefits are limited, primarily observed when combined with effective chemotherapy or radiation therapy for specific cancers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: